Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 5 | $215,061 |
| Sells | 15 | $38,762,036 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 09 Dec 2022 19:41 | TXMD | TherapeuticsMD Inc | BERNICK BRIAN | Co-Chief Executive Officer | 06 Dec 2022 | Sale | 935 | 4.9215 | 4,602 | D |
| 09 Dec 2022 19:37 | TXMD | TherapeuticsMD Inc | DONEGAN MICHAEL C | Interim CFO/CAO/VP of Finance | 06 Dec 2022 | Sale | 910 | 4.775 | 4,345 | D |
| 09 Dec 2022 19:38 | TXMD | TherapeuticsMD Inc | GLICKMAN MARK A | Co-Chief Executive Officer | 06 Dec 2022 | Sale | 440 | 4.9215 | 2,165 | D |
| 09 Dec 2022 19:38 | TXMD | TherapeuticsMD Inc | WALKER MARLAN D | General Counsel | 06 Dec 2022 | Sale | 1,048 | 4.9475 | 5,185 | D |
| 09 Dec 2022 10:58 | TXMD | TherapeuticsMD Inc | RUBRIC CAPITAL MANAGEMENT LP | 10% | 07 Dec 2022 | Purchase | 20,113 | 5.6625 | 113,890 | I |
| 08 Dec 2022 20:10 | TXMD | TherapeuticsMD Inc | NAUGHTON GAIL K | Director | 07 Dec 2022 | Sale | 3,922 | 5.2614 | 20,635 | D |
| 09 Dec 2022 10:58 | TXMD | TherapeuticsMD Inc | RUBRIC CAPITAL MANAGEMENT LP | 10% | 08 Dec 2022 | Purchase | 300 | 5.83 | 1,749 | I |
| 12 Dec 2022 11:14 | TXMD | TherapeuticsMD Inc | RUBRIC CAPITAL MANAGEMENT LP | 10% | 09 Dec 2022 | Purchase | 14,825 | 6.09 | 90,284 | I |
| 09 Dec 2022 19:41 | TXMD | TherapeuticsMD Inc | BERNICK BRIAN | Co-Chief Executive Officer | 09 Dec 2022 | Sale | 320 | 6.3121 | 2,020 | D |
| 03 Jan 2023 15:33 | TXMD | TherapeuticsMD Inc Preferred |
RUBRIC CAPITAL MANAGEMENT LP | 10% | 30 Dec 2022 | Sale | 29,000 | 1,333 | 38,657,000 | I |
| 25 Jan 2023 17:50 | TXMD | TherapeuticsMD Inc | DONEGAN MICHAEL C | Prin. Fin. and Acctg. Officer | 23 Jan 2023 | Sale | 1,302 | 5.3383 | 6,950 | D |
| 25 Jan 2023 17:50 | TXMD | TherapeuticsMD Inc | DONEGAN MICHAEL C | Prin. Fin. and Acctg. Officer | 24 Jan 2023 | Sale | 7 | 5.3101 | 37 | D |
| 30 Jan 2023 18:40 | TXMD | TherapeuticsMD Inc | DONEGAN MICHAEL C | Prin. Fin. and Acctg. Officer | 26 Jan 2023 | Sale | 1,648 | 5.0796 | 8,371 | D |
| 30 Jan 2023 18:40 | TXMD | TherapeuticsMD Inc | DONEGAN MICHAEL C | Prin. Fin. and Acctg. Officer | 27 Jan 2023 | Sale | 49 | 5.09 | 249 | D |
| 14 Apr 2023 19:20 | TXMD | TherapeuticsMD Inc | WALKER MARLAN D | Chief Executive Officer | 12 Apr 2023 | Sale | 1,170 | 3.6543 | 4,276 | D |
| 04 May 2023 16:38 | TXMD | TherapeuticsMD Inc | WALKER MARLAN D | Chief Executive Officer | 26 Apr 2023 | Sale A | 692 | 3.6381 | 2,518 | D |
| 07 Dec 2023 16:51 | TXMD | TherapeuticsMD Inc | WALKER MARLAN D | Chief Executive Officer | 06 Dec 2023 | Sale | 14,500 | 2.3101 | 33,496 | D |
| 07 Dec 2023 16:51 | TXMD | TherapeuticsMD Inc | WALKER MARLAN D | Chief Executive Officer | 07 Dec 2023 | Sale | 4,550 | 2.239 | 10,187 | D |
| 23 Aug 2024 18:18 | TXMD | TherapeuticsMD Inc | COLLINS COOPER C. | Director | 21 Aug 2024 | Purchase | 1,200 | 1.6988 | 2,039 | D |
| 26 Aug 2024 17:40 | TXMD | TherapeuticsMD Inc | COLLINS COOPER C. | Director | 22 Aug 2024 | Purchase | 4,094 | 1.734 | 7,099 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)